Clinical Trials Logo

Clinical Trial Summary

This observational study is being conducted to determine plasma concentrations of tetrahydrocannabinol (THC) and its metabolites, 11-OH-THC and THC-COOH, in plasma of subjects who visit the emergency department due to acute cannabinoid intoxication.


Clinical Trial Description

This is a multi-center, prospective, cross-sectional observational study to determine the concentrations of tetrahydrocannabinol (THC) and its metabolites (and/or other cannabinoids) in the plasma of subjects admitted to emergency departments with acute cannabinoid intoxication The study will explore the relationships between these concentrations and parameters such as demographics, symptom severity, time to symptom resolution, and clinical outcomes. Samples will be collected as part of standard clinical procedure without requiring study participants to spend additional time in the hospital. ;


Study Design


NCT number NCT06017622
Study type Observational
Source Anebulo Pharmaceuticals
Contact Linda Klumpers, PhD
Phone 512-598-0931
Email linda@anebulo.com
Status Recruiting
Phase
Start date June 1, 2023
Completion date June 30, 2024